DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b4g2bm/crohns_disease) has announced the addition of the "Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Crohn's Disease (Regional Enteritis)and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Crohn's Disease (Regional Enteritis)Overview
- Therapeutics Development
- Pipeline Products for Crohn's Disease (Regional Enteritis)- Overview
- Pipeline Products for Crohn's Disease (Regional Enteritis)- Comparative Analysis
- Crohn's Disease (Regional Enteritis)- Therapeutics under Development by Companies
- Crohn's Disease (Regional Enteritis)- Therapeutics under Investigation by Universities/Institutes
- Crohn's Disease (Regional Enteritis)- Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Crohn's Disease (Regional Enteritis)- Products under Development by Companies
- Crohn's Disease (Regional Enteritis)- Products under Investigation by Universities/Institutes
- Crohn's Disease (Regional Enteritis)- Companies Involved in Therapeutics Development
Companies Mentioned - Sample List
- 4D Pharma Plc
- 4SC AG
- AB Science SA
- AbbVie Inc.
- Alba Therapeutics Corporation
- Alfa Wassermann S.p.A
- Allozyne, Inc.
- Altheus Therapeutics, Inc.
- Amgen Inc.
- Ampio Pharmaceuticals, Inc.
- Arena Pharmaceuticals, Inc.
- Avaxia Biologics, Inc.
- BioAtla, LLC
- BIOCAD
- BioLingus AG
- Bionovis SA
- BioTherapeutics Inc.
- Boehringer Ingelheim GmbH
- Calypso Biotech SA
- Celgene Corporation
- Celltrion, Inc.
- ChemoCentryx, Inc.
- ChironWells GmbH
- Chong Kun Dang Pharmaceutical Corp.
- CLL Pharma
- Commence Bio, Inc.
- Daiichi Sankyo Company, Limited
- DBV Technologies S.A.
- Eisai Co., Ltd.
- Eli Lilly and Company
- Emergent BioSolutions Inc.
- Enterome Bioscience SA
- Enzo Biochem, Inc.
- Epirus Biopharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
For more information visit http://www.researchandmarkets.com/research/b4g2bm/crohns_disease
